Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimers disease

Brain Research

Volumn 1597, Issue , 2015, Pages 159-167

  Bi Oh, Shin ^a   Suh, Nayoung ^a   Kim, Inki ^a   Lee, Joo Yong ^a,b  

^a Asan Medical Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Amyloid degrading enzymes; Amyloid pathogenesis; Amyloid plaques; Plasmin

Indexed keywords

AMYLOID BETA PROTEIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN; PROTEASE NEXIN I; SERPINE2 PROTEIN, MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN TISSUE; CONTROLLED STUDY; GLIA CELL; GRANULE CELL; HIPPOCAMPAL CA1 REGION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; ANIMAL; BRAIN CORTEX; C57BL MOUSE; DISEASE MODEL; FEMALE; GENETICS; GLIA; HIPPOCAMPUS; HUMAN; METABOLISM; NERVE CELL; PATHOLOGY; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; FIBRINOLYSIN; HIPPOCAMPUS; HUMANS; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROGLIA; NEURONS; PLAQUE, AMYLOID; SERPIN E2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84923238811     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.11.042     Document Type: Article

References (30)

1. D.F. Alonso, E.F. Farias, A.L. Famulari, R.O. Dominguez, S. Kohan, and E.S. de Lustig Excessive urokinase-type plasminogen activator activity in the euglobulin fraction of patients with Alzheimer-type dementia J. Neurol Sci. 139 1996 83 88
2. D.X. Beringer, M.J. Fischer, J.D. Meeldijk, E.G. van Donselaar, N.J. de Mol, and L.M. Kroon-Batenburg Tissue-type plasminogen activator binds to Abeta and AIAPP amyloid fibrils with multiple domains Amyloid 20 2013 113 121
3. M. Cacquevel, S. Launay, H. Castel, K. Benchenane, S. Cheenne, L. Buee, L. Moons, A. Delacourte, P. Carmeliet, and D. Vivien Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms Neurobiol. Dis. 27 2007 164 173
4. E. Cho, K.J. Lee, J.W. Seo, C.J. Byun, S.J. Chung, D.C. Suh, P. Carmeliet, J.Y. Koh, J.S. Kim, and J.Y. Lee Neuroprotection by urokinase plasminogen activator in the hippocampus Neurobiol. Dis. 46 2012 215 224
5. J. Davis, M.R. Wagner, W. Zhang, F. Xu, and W.E. Van Nostrand Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells J. Biol. Chem. 278 2003 19054 19061
6. N. Ertekin-Taner, J. Ronald, L. Feuk, J. Prince, M. Tucker, L. Younkin, M. Hella, S. Jain, A. Hackett, L. Scanlin, J. Kelly, M. Kihiko-Ehman, M. Neltner, L. Hersh, M. Kindy, W. Markesbery, M. Hutton, M. de Andrade, R.C. Petersen, N. Graff-Radford, S. Estus, A.J. Brookes, and S.G. Younkin Elevated amyloid beta protein (Abeta42) and late onset Alzheimers disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene Hum. Mol. Genet. 14 2005 447 460
7. C. Exley, and O.V. Korchazhkina Plasmin cleaves Abeta42 in vitro and prevents its aggregation into beta-pleated sheet structures Neuroreport 12 2001 2967 2970
8. U. Finckh, K. van Hadeln, T. Muller-Thomsen, A. Alberici, G. Binetti, C. Hock, R.M. Nitsch, G. Stoppe, J. Reiss, and A. Gal Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2 Neurogenetics 4 2003 213 217
9. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
10. I.B. Kingston, M.J. Castro, and S. Anderson In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues Nat. Med 1 1995 138 142
11. O. Kranenburg, B. Bouma, L.M. Kroon-Batenburg, A. Reijerkerk, Y.P. Wu, E.E. Voest, and M.F. Gebbink Tissue-type plasminogen activator is a multiligand cross-beta structure receptor Curr. Biol. 12 2002 1833 1839
12. A. Krystosek, and N.W. Seeds Plasminogen activator secretion by granule neurons in cultures of developing cerebellum P. Natl. Acad. Sci. USA. 78 1981 7810 7814
13. M.D. Ledesma, J.S. Da Silva, K. Crassaerts, A. Delacourte, B. De Strooper, and C.G. Dotti Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimers disease brains EMBO Rep. 1 2000 530 535
14. J.Y. Lee, H.S. Kweon, E. Cho, H.R. Byun, D.H. Kim, Y.H. Kim, P.L. Han, and J.Y. Koh Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimers disease Neurosci. Lett. 423 2007 82 87
15. J.Y. Lee, E. Cho, J.W. Seo, J.J. Hwang, and J.Y. Koh Alteration of the cerebral zinc pool in a mouse model of Alzheimer disease J. Neuropath. Exp. Neur. 71 2012 211 222
16. R.M. Liu, T.K.A. van Groen, D. Cao, I. Kadisha, C. Ballinger, L. Wang, S.L. Carroll, and L. Li Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimers disease Neurobiol. Aging 32 2011 1079 1089
17. C. Maas, B. Schiks, R.D. Strangi, T.M. Hackeng, B.N. Bouma, M.F. Gebbink, and B. Bouma Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs Amyloid 15 2008 166 180
18. J.P. Melchor, R. Pawlak, and S. Strickland The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration J. Neurosci. 23 2003 8867 8871
19. D.L. Miller, I.A. Papayannopoulos, J. Styles, S.A. Bobin, Y.Y. Lin, K. Biemann, and K. Iqbal Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimers disease Arch. Biochem. Biophys. 301 1993 41 52
20. P. Nathalie, and O. Jean-Noel Processing of amyloid precursor protein and amyloid peptide neurotoxicity Curr. Alz. Res. 5 2008 92 99
21. S.B. Oh, C.J. Byun, J.H. Yun, D.G. Jo, P. Carmeliet, J.Y. Koh, and J.Y. Lee Tissue plasminogen activator arrests Alzheimers disease pathogenesis Neurobiol. Aging 35 2014 511 519
22. Z. Qian, M.E. Gilbert, M.A. Colicos, E.R. Kandel, and D. Kuhl Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation Nature 361 1993 453 457
23. M. Riemenschneider, L. Konta, P. Friedrich, S. Schwarz, K. Taddei, F. Neff, A. Padovani, H. Kolsch, S.M. Laws, N. Klopp, H. Bickeboller, S. Wagenpfeil, J.C. Mueller, A. Rosenberger, J. Diehl-Schmid, S. Archetti, N. Lautenschlager, B. Borroni, U. Muller, T. Illig, R. Heun, R. Egensperger, J. Schlegel, H. Forstl, R.N. Martins, and A. Kurz A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimers disease Hum. Mol. Genet. 15 2006 2446 2456
24. B.D. Roussel, R. Macrez, A. Jullienne, V Agin, E. Maubert, L. Dauphinot, M.C. Potier, L. Plawinski, H. Castel, Y. Hommet, J. Munuera, J. Montaner, M. Yepes, C. Ali, and D. Vivien Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact Brain 132 2009 2219 2230
25. C.J. Siao, S.R. Fernandez, and S.E. Tsirka Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury J. Neurosci. 23 2003 3234 3242
26. T. Teesalu, A. Kulla, A. Simisker, V. Siren, D.A. Lawrence, T. Asser, and A. Vaheri Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system Thromb. Haemostasis 92 2004 358 368
27. H.M. Tucker, M. Kihiko, J.N. Caldwell, S. Wright, T. Kawarabayashi, D. Price, D. Walker, S. Scheff, J.P. McGillis, R.E. Rydel, and S. Estus The plasmin system is induced by and degrades amyloid-beta aggregates J. Neurosci. 20 2000 3937 3946
28. H.M. Tucker, M. Kihiko-Ehmann, and S. Estus Urokinase-type plasminogen activator inhibits amyloid-beta neurotoxicity and fibrillogenesis via plasminogen J. Neurosci. Res. 70 2002 249 255
29. W.E. Van Nostrand, and M. Porter Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity Biochemistry 38 1999 11570 11576
30. S. Wnendt, I. Wetzels, and W.A. Gunzler Amyloid beta peptides stimulate tissue-type plasminogen activator but not recombinant prourokinase Thromb. Res. 85 1997 217 224